Aggressive Combination Drug Therapy in Very Early Polyarticular Juvenile Idiopathic Arthritis

Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2009
The objective of this study is to compare in very early polyarticular juvenile idiopathic arthritis (JIA) the efficacy, safety, and cost-benefit-ratio of three treatment strategies: biologic combination, combination of conventional disease-modifying drugs (DMARDs), and methotrexate alone.
Epistemonikos ID: 5b48ff630bbed8f3abe755010e540674797d78b7
First added on: Mar 23, 2022